INVEGA SUSTENNA PALIPERIDONE 150MG/ML INJECTION – 1

Invega Sustenna (paliperidone palmitate) is an antipsychotic medication primarily used for the treatment of schizophrenia and schizoaffective disorder in adults. It is administered as a long-acting injectable formulation, allowing for once-monthly dosing, which enhances adherence to treatment.

The drug works by modulating the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which are believed to play a key role in mood and behavior regulation.

Invega Sustenna is particularly beneficial for patients who may struggle with daily oral medication regimens, providing a more consistent therapeutic effect. It can help reduce the risk of relapse in individuals with schizophrenia and improve overall functioning and quality of life.

Common side effects may include weight gain, sedation, and extrapyramidal symptoms, but it is generally well-tolerated when monitored appropriately.